Safety evaluation of stem cells used for clinical cell therapy in chronic liver diseases; with emphasize on biochemical markers

Clinical Biochemistry

Volumn 45, Issue 6, 2012, Pages 385-396

  Allameh, Abdolamir ^a   Kazemnejad, Somaieh ^b  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b UNIVERSITY OF GUILAN   (Iran)

Author keywords

Biochemical; Hepatocytes; Molecular markers; Safety evaluation; Stem cell

Indexed keywords

ALBUMIN; ALPHA 1 ANTITRYPSIN; ALPHA 2 MACROGLOBULIN; ALPHA FETOPROTEIN; ANTITHROMBIN; BILIRUBIN; BIOCHEMICAL MARKER; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 9; C REACTIVE PROTEIN; CCAAT ENHANCER BINDING PROTEIN ALPHA; CD14 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; CERULOPLASMIN; COMPLEMENT COMPONENT C3; CYTOCHROME P450 2B6; FIBRINOGEN; GLUCOSE 6 PHOSPHATASE; GLUTATHIONE TRANSFERASE P1; IMMUNOSUPPRESSIVE AGENT; LIPOPROTEIN; PROTHROMBIN; TRANSFERRIN; TRYPTOPHAN 2,3 DIOXYGENASE; TYROSINE AMINOTRANSFERASE;

ACUTE LIVER FAILURE; ADULT STEM CELL; ALBUMIN BLOOD LEVEL; ALCOHOL LIVER CIRRHOSIS; BILIRUBIN BLOOD LEVEL; BLOOD GROUP ABO INCOMPATIBILITY; BONE MARROW DEPRESSION; CELL CULTURE; CELL DIFFERENTIATION; CELL FUNCTION; CELL ISOLATION; CELL MATURATION; CHRONIC LIVER DISEASE; CHRONIC LIVER FAILURE; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; DIABETES MELLITUS; DIARRHEA; DONOR SELECTION; DOWN REGULATION; EMBRYONIC STEM CELL; ENZYME BLOOD LEVEL; EXTRACELLULAR MATRIX; GRAFT REJECTION; HEMATOPOIETIC STEM CELL; HEMOLYTIC ANEMIA; HEPATOCYTE TRANSPLANTATION; HIRSUTISM; HUMAN; HYPERLIPIDEMIA; HYPERSENSITIVITY REACTION; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INBORN ERROR OF METABOLISM; INFECTION; INTERNATIONAL NORMALIZED RATIO; KIDNEY DISEASE; LIVER CANCER; LIVER CELL; LIVER FUNCTION TEST; LIVER INJURY; LIVER TOXICITY; LIVER TRANSPLANTATION; LUNG EDEMA; MESENCHYMAL STEM CELL; MONOCYTE; MULTIPOTENT STEM CELL; NEUROLOGIC DISEASE; NEUTROPENIA; OBESITY; ORGAN DONOR; OSTEOPOROSIS; OUTCOME ASSESSMENT; PATIENT SAFETY; PHENOTYPE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTHROMBIN TIME; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RISK ASSESSMENT; STEM CELL MOBILIZATION; STEM CELL TRANSPLANTATION; SURVIVAL; THROMBOCYTOPENIA; TISSUE DIFFERENTIATION; TISSUE REGENERATION;

ANIMALS; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CLINICAL TRIALS AS TOPIC; END STAGE LIVER DISEASE; HUMANS; LIVER; LIVER TRANSPLANTATION; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 84858444953     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2012.01.017     Document Type: Review

References (161)

1. Enns G.M., Millan M.T. Cell-based therapies for metabolic liver disease. Mol Genet Metab 2008, 95:3-10.
2. Burdelski M., Rogiers X. Liver transplantation in metabolic disorders. Acta Gastroenterol Belg 1999, 62(3):300-305.
3. Squires R.H., Shneider B.L., Bucuvalas J., Alonso E., Sokol R.J., Narkewicz M.R., et al. Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr 2006, 148:652-658.
4. Williams R. Classification, etiology, and considerations of outcome in acute liver failure. Semin Liver Dis 1996, 16:343-348.
5. Sokal E.M., Goldstein D., Ciocca M.J., Lewindon P., Ni Y.H., Silveira T., et al. End-stage liver disease and liver transplant: current situation and key issues. J Pediatr Gastroenterol Nutr 2008, 47:239-246.
6. Lucey M.R., Schaubel D.E., Guidinger M.K., Tome S., Merion R.M. Effect of alcoholic liver disease and hepatitis C infection on waiting list and posttransplant mortality and transplant survival benefit. Hepatology 2009, 50:400-406.
7. Do H., Healey J.F., Waller E.K., Lollar P. Expression of factor VIII by murine liver sinusoidal endothelial cells. J Biol Chem 1999, 274(28):19,587-19,592.
8. Wang X., Al-Dhalimy M., Lagasse E., Finegold M., Grompe M. Liver repopulation and correction of metabolic liver disease by transplanted adult mouse pancreatic cells. Am J Pathol 2001, 158(2):571-579.
9. Kumaran V., Benten D., Follenzi A., Joseph B., Sarkar R., Gupta S. Transplantation of endothelial cells corrects the phenotype in hemophilia A mice. J Thromb Haemost 2005, 3(9):2022-2031.
10. Ruhnke M., Nussler A.K., Ungefroren H., Hengstler J.G., Kremer B., Hoeckh W., et al. Human monocyte-derived neohepatocytes: a promising alternative to primary human hepatocytes for autologous cell therapy. Transplantation 2005, 79(9):1097-1103.
11. Hua L., Aoki T., Jin Z., Nishino N., Yasuda D., Izumida Y., et al. Elevation of serum albumin levels in nagase analbuminemic rats by allogeneic bone marrow cell transplantation. Eur Surg Res 2005, 37(2):111-114.
12. Arias I.M., Boyer J.L., Fausto N., Jakoby W.B., Schachter D., Shafritz D.A., et al. The liver: biology and pathobiology 2001, Raven Press Ltd., New York. Fourth ed.
13. Diseases of the liver 1993, vols. 1 and 2. J.B. Lippincott, Philadelphia. 7th ed. L. Schiff, E.R. Schiff (Eds.).
14. Hepatology: a textbook of liver disease 1996, vols. I and II. WB Saunders, Philadelphia. 3rd ed. D. Zakim, T.D. Boyer (Eds.).
15. Michalopoulos G.K. Liver regeneration. J Cell Physiol 2007, 213:286-300.
16. Fatemi F., Allameh A., Dadkhah A., Forouzandeh M., Kazemnejad S., Sharifi R. Changes in hepatic cytosolic glutathione S-transferase activity and expression of its class-P during prenatal and postnatal period in rats treated with aflatoxin B1. Arch Toxicol 2006, 80(9):572-579.
17. Lavon N., Benvenisty N. Study of hepatocyte differentiation using embryonic stem cells. J Cell Biochem 2005, 96:1193-1202.
18. Ghaderi M., Allameh A., Soleimani M., Rastegar H., Ahmadi-Ashtiani H.R. A comparison of DNA damage induced by aflatoxin B1 in hepatocyte-like cells, their progenitor mesenchymal stem cells and CD34(+) cells isolated from umbilical cord blood. Mutat Res 2011, 3(719):14-20.
19. Snykers S., De Kock J., Tamara V., Rogiers V. Hepatic differentiation of mesenchymal stem cells: in vitro strategies. Methods Mol Biol 2011, 698:305-325.
20. Rhodes S.P., Otten J.N., Hingorani G.P., Hartley D.P., Franklin R.B. Simultaneous assessment of cytochrome P450 activity in cultured human hepatocytes for compound-mediated induction of CYP3A4, CYP2B6, and CYP1A2. J Pharmacol Toxicol Methods 2011, 63(3):223-226.
21. Tan E.H., Ma F.J., Gopinadhan S., Sakban R.B., Wang N.D. C/EBP alpha knock-in hepatocytes exhibit increased albumin secretion and urea production. Cell Tissue Res 2007, 330(3):427-435.
22. Nagaki M., Shidoji Y., Yamada Y., Sugiyama A., Tanaka M., Akaike T., et al. Regulation of hepatic genes and liver transcription factors in rat hepatocytes by extracellular matrix. Biochem Biophys Res Commun 1995, 210:38-43.
23. Kimata T., Nagaki M., Tsukada Y., Ogiso T., Moriwaki H. Hepatocyte nuclear factor-4 alpha and -1 small interfering RNA inhibits hepatocyte differentiation induced by extracellular matrix. Hepatol Res 2006, 35:3-9.
24. Rambhatla L., Chiu C.P., Kundu P., Peng Y., Carpenter M.K. Generation of hepatocyte-like cells from human embryonic stem cells. Cell Transplant 2003, 12:1-11.
25. Bismuth H., Houssin D. Reduced-sized orthotopic liver graft in hepatic transplantation in children. Surgery 1984, 95:367-370.
26. Samuel D., Bismuth A., Mathieu D., Arulnaden J.L., Reynes M., Benhamou J.P., et al. Passive immunoprophylaxis after liver transplantation in HBs Ag-positive patients. Lancet 1991, 337:813-815.
27. Terpstra O.T., Schalm S.W., Weimar W., Willemse P.J., Baumgartner D., Groenland T.H., et al. Auxiliary partial liver transplantation for end-stage chronic liver disease. N Engl J Med 1988, 319:1507-1511.
28. Boudjema K., Cherqui D., Jaeck D., Chenard-Neu M.P., Steib A., Freis G., et al. Auxiliary liver transplantation for fulminant and subfulminant hepatic failure. Transplantation 1995, 59:218-223.
29. Metselaar H.J., Hesselink E.J., De Rave S., Ten Kate F.J., Lameris J.S., Groenland T.H., et al. Recovery of failing liver after auxiliary heterotopic transplantation. Lancet 1990, 335:1156-1157.
30. Wiesner R., Edwards E., Freeman R., Harper A., Kim R., Kamath P., et al. Model for end-stage liver disease (MELD) and allocation of liver donors. Gastroenterology 2003, 124:91-96.
31. Ballarin R., Montalti R., Spaggiari M., Cautero N., De Ruvo N., Guerrini G.P., et al. Liver transplgyantation in older adults: our point of view. J Am Geriatr Soc 2011, 59:1359-1361.
32. Sugarawa Y., Makuuchi M., Kaneko J., Kokudoet N. MELD score for selection of patients to receive left liver graft. Transplantation 2003, 75:573-574.
33. Talwalkar J.A., Seaberg E., Kim W.R., Wiesner R.H. Predicting clinical and economic outcomes after liver transplantation using the Mayo primary sclerosing cholangitis model and Child-Pugh score. Liver Transpl 2000, 6:753-758.
34. Liu C.L., Lam B., Lo C.M. Impact of right-lobe live donor liver transplantation on patients waiting for liver transplantation. Liver Transpl 2003, 9:863-869.
35. Russo M.W., LaPointe-Rudow D., Kinkhabwala M., Emond J., Brown R.S. Impact of adult living donor liver transplantation on waiting time survival in candidates listed for liver transplantation. Am J Transplant 2004, 4:427-431.
36. Trotter J.F., Wachs M., Trouillot T., Steinberg T., Bak T., Everson G.T., et al. Evaluation of 100 patients for living donor liver transplantation. Liver Transpl 2000, 6:290-295.
37. Tan H.P., Patel-Tom K., Marcos A. Adult living donor liver transplantation: who is the ideal donor and recipient?. J Hepatol 2005, 43:13-17.
38. Trotter J.F., Hayashi P.H., Kam I. Donor and recipient evaluation and selection for adult-to-adult right hepatic lobe liver transplant. Transplantation of the liver 2005, 655-674. Elsevier Saunders, Philadelphia. 2nd ed.
39. Munoz S.J., Rothstein K.D., Reich D., Manzarbeitia C. Long-term care of the liver transplant recipient. Clin Liver Dis 2000, 4:691-710.
40. Rosen H.R., Martin P. Hepatitis B and C in the liver transplant recipient. Semin Liver Dis 2000, 20:465-480.
41. Reddy K.R., Faust T. The clinician's guide to liver disease 2006, SLACK incorporated, Thorofare, NJ08086, USA. First ed.
42. George M.J., Snydman D.R., Werner B.G., Griffith J., Falagas M.E., Dougherty N.N., et al. The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients, Boston Center for Liver Transplantation CMVIG-Study Group. Cytogam, MedImmune, Inc. Gaithersburg, Maryland. Am J Med 1997, 103:106-113.
43. Everson G.T., Karn I. Immediate postoperative care. Transplantation of the liver 1999, 131-162. Lippincott Williams & Wilkins, Philadelphia. 3rd ed. W.C. Maddrey, E.R. Schiff, M.F. Sorrell (Eds.).
44. Bhogal R.H., Hodson J., Bartlett D.C., Weston C.J., Curbishley S.M., Haughton E., et al. Isolation of primary human hepatocytes from normal and diseased liver tissue: a one hundred liver experience. PLoS One 2011, 6(3):e18222. 29.
45. Fisher R.A., Strom S.C. Human hepatocyte transplantation: worldwide results. Transplantation 2006, 82(4):441-449.
46. Fox I.J., Chowdhury J.R., Kaufman S.S., Goertzen T.C., Chowdhury N.R., Warkentin P.I., et al. Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N Engl J Med 1998, 338(20):1422-1426.
47. Muraca M.M., Gerunda G., Neri D., Vilei M.T., Granato A., Feltracco P., et al. Hepatocyte transplantation as a treatment for glycogen storage disease type 1a. Lancet 2002, 359(9303):317-318.
48. Lee K.W., Lee J.H., Shin S.W., Kim S.J., Joh J.W., Lee D.H., et al. Hepatocyte transplantation for glycogen storage disease type Ib. Cell Transplant 2007, 16(6):629-637.
49. Stephenne X., Najimi M., Sibille C., Nassogne M.C., Smets F., Sokal E.M. Sustained engraftment and tissue enzyme activity after liver cell transplantation for argininosuccinate lyase deficiency. Gastroenterology 2006, 130(4):1317-1323.
50. Fox I.J., Chowdhury J.R. Hepatocyte transplantation. Am J Transplant 2004, 4:7-13.
51. Mitry R.R., Hughes R.D., Aw M.M., Terry C., Mieli-Vergani G., Girlanda R., et al. Human hepatocyte isolation and relationship of cell viability to early graft function. Cell Transplant 2003, 12:69-74.
52. Hughes R.D., Mitry R.R., Dhawan A., Lehec S.C., Girlanda R., Rela M., et al. Isolation of hepatocytes from livers from non-heart-beating donors for cell transplantation. Liver Transpl 2003, 12:713-717.
53. Muiesan P. Can controlled non heart-beating donors provide a solution to the organ shortage?. Transplantation 2003, 75:1627-1628.
54. Balladur P., Crema E., Honiger J., Calmus Y., Baudrimont M., Delelo R., et al. Transplantation of allogeneic hepatocytes without immunosuppression: long term survival. Surgery 1995, 117:189-194.
55. Moghe P.V., Berthiaume F., Ezzell R.M., Toner M., Tompkins R.G., Yarmush M.L. Culture matrix configuration and composition in the maintenance of hepatocyte polarity and function. Biomaterials 1996, 17:373-385.
56. Runge D., Runge D.M., Jager D., Lubecki K.A., Beer S.D., Karathanasis S., et al. Serum-free, long-term cultures of human hepatocytes: maintenance of cell morphology, transcription factors, and liver-specific functions. Biochem Biophys Res Commun 2000, 269:46-53.
57. G. Pless G, I.M. Sauer, U. Rauen. Improvement of the cold storage of isolated human hepatocytes, Cell. Transplant 2011 Jun 7. [Epub ahead of print].
58. Wang X., Foster M., Al-Dhalimy M., Lagasse E., Finegold M., Grompe M. The origin and liver repopulating capacity of murine oval cells. Proc Natl Acad Sci U S A 2003, 100(Suppl. 1):11,881-11,888.
59. Ohashi K., Waugh J.M., Dake M.D., Yokoyama T., Kuge H., Nakajima Y., et al. Liver tissue engineering at extrahepatic sites in mice as a potential new therapy for genetic liver diseases. Hepatology 2005, 41(1):132-140.
60. Cai J., Zhao Y., Liu Y., Ye F., Song Z., Qin H., et al. Directed differentiation of human embryonic stem cells into functional hepatic cells. Hepatology 2007, 45(5):1229-1239.
61. Russo F.P., Parola M. Stem and progenitor cells in liver regeneration and repair. Cytotherapy 2011, 13(2):135-144.
62. Oertel M., Shafritz D.A. Stem cells, cell transplantation and liver repopulation. Biochem Biophys Acta 2008, 1782(2):61-74.
63. Wobus A.M., Boheler K.R. Embryonic stem cells: prospects for developmental biology and cell therapy. Physiol Rev 2005, 85:635-678.
64. Itskovitz-Eldor J., Schuldiner M., Karsenti D., Eden A., Yanuka O., Amit M., et al. Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers. Mol Med 2000, 6:88-95.
65. Kim J.H., Auerbach J.M., Rodriguez-Gomez J.A., Velasco I., Gavin D., Lumelsky N., et al. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature 2002, 418:50-56.
66. Kehat I., Khimovich L., Caspi O., Gepstein A., Shofti R., Arbel G., et al. Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat Biotechnol 2004, 22:1282-1289.
67. Lako M., Lindsay S., Lincoln J., Cairns P.M., Armstrong L., Hole N. Characterisation of Wnt gene expression during the differentiation of murine embryonic stem cells in vitro: role of Wnt3 in enhancing haematopoietic differentiation. Mech Dev 2001, 103:49-59.
68. Suzuki H., Watabe T., Kato M., Miyazawa K., Miyazono K. Roles of vascular endothelial growth factor receptor 3 signaling in differentiation of mouse embryonic stem cell-derived vascular progenitor cells into endothelial cells. Blood 2005, 105:372-2379.
69. D'Amour K.A., Bang A.G., Eliazer S., Kelly O.G., Agulnick A.D., Smart N.G., et al. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat Biotechnol 2004, 24:1392-1401.
70. Zhao D., Rivas-Carrillo J.D., Lebkowski J., Tanaka N., Fox I.J., et al. Differentiation of mouse embryonic stem cells to hepatocyte-like cells by co-culture with human liver nonparenchymal cell lines. Nat Protoc 2007, 2:347-356.
71. Chen X., Zeng F. Directed hepatic differentiation from embryonic stem cells. Protein Cell 2011, 2(3):180-188.
72. Moore R.N., Dasgupta A., Rajaei N., et al. Enhanced differentiation of embryonic stem cells using co-cultivation with hepatocytes. Biotechnol Bioeng 2008, 101:1332-1343.
73. Kubo A., Shinozaki K., Shannon J.M., Kouskoff V., Kennedy M., Woo S. Development of definitive endoderm from embryonic stem cells in culture. Development 2004, 131:1651-1662. et al.
74. Zhou M., Li P., Tan L., Qu S., Ying Q.L., Song H. Differentiation of mouse embryonic stem cells into hepatocytes induced by a combination of cytokines and sodium butyrate. J Cell Biochem 2010, 109:606-614.
75. Polak J.M., Bishop A.E. Stem cells and tissue engineering: past, present, and future. Ann NY Acad Sci 2006, 1068:352-366.
76. Martin G.R. Isolation of pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci 1981, 78:7634-7638.
77. Chinzei R., Tanaka Y., Shimizu-Saito K., Hara Y., Kakinuma S., Watanabe M., et al. Embryoid body cells derived from a mouse embryonic stem cell line show differentiation into functional hepatocytes. Hepatology 2002, 36:22-29.
78. Payne C.M., Samuel K., Pryde A., King J., Brownstein D., Schrader J., et al. Persistence of functional hepatocyte-like cells in immune-compromised mice. Liver Int 2011, 31:254-262.
79. Kumashiro Y., Asahina K., Ozeki R., Shimizu-Saito K., Tanaka Y., Kida Y., et al. Enrichment of hepatocytes differentiated from mouse embryonic stem cells as a transplantable source. Transplantation 2005, 79:550-557.
80. Roelen B.A., Chuva De Sousa Lopes S. Origins of pluripotent stem cells. Minerva Ginecol 2011, 63(4):351-363.
81. Park I.H., Zhao R., West J.A., Yabuuchi A., Huo H., Ince T.A., et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 2008, 451:141-146.
82. Zhao T., Zhang Z.N., Rong Z., Xu Y. Immunogenicity of induced pluripotent stem cell. Nature 2011, 474:212-215.
83. Lyra A.C., Soares M.B., Dos Santos R.R. Bone marrow stem cells and liver diseases. Gut 2007, 56:716-724.
84. Ezzat T.M., Dhar D.K., Newsome N.P., Malago M., Olde Damink S.W. Use of hepatocyte and stem cells for treatment of post-resectional liver failure: are we there yet?. Liver Int 2011, 31(6):773-784.
85. Austin T.W., Lagasse E. Hepatic regeneration from hematopoietic stem cells. Mech Dev 2003, 120:131-135.
86. Jang Y.Y., Collector M.I., Baylin S.B., Diehl A.M., Sharkis S.J. Hematopoietic stem cells convert into liver cells within days without fusion. Nat Cell Biol 2004, 6:532-539.
87. Avital I., Inderbitzin D., Aoki T., Tyan D.B., Cohen A.H., Ferraresso C., et al. Isolation, characterization, and transplantation of bone marrow-derived hepatocyte stem cells. Biochem Biophys Res Commun 2001, 288:156-164.
88. Saji Y., Tamura S., Yoshida Y., Kiso S., Iizuka A.S., Matsumoto H., et al. Basic fibroblast growth factor promotes the trans-differentiation of mouse bone marrow cells into hepatic lineage cells via multiple liver-enriched transcription factors. J Hepatol 2004, 41:545-550.
89. Lagasse E., Connors H., Al-Dhalimy M., Reitsma M., Dohse M., Osborne L., et al. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med 2000, 6(11):1229-1234.
90. Willenbring H., Bailey A.S., Foster M., Akkari Y., Dorrell C., Olson S., et al. Myelomonocytic cells are sufficient for therapeutic cell fusion in liver. Nat Med 2004, 10(7):744-748.
91. Harb R., Xie G., Lutzko C., Guo Y., Wang X., Hill C.K., et al. Bone marrow progenitor cells repair rat hepatic sinusoidal endothelial cells after liver injury. Gastroenterology 2009, 137:704-712.
92. Gehling U.M., Willems M., Dandri M., Petersen J., Berna M., Thill M., et al. Partial hepatectomy induces mobilization of a unique population of haematopoietic progenitor cells in human healthy liver donors. J Hepatol 2005, 43(5):845-853.
93. Son B.R., Marquez-Curtis L.A., Kucia M., Wysoczynski M., Turner A.R., Ratajczak J., et al. Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth factor-c-met axes and involves matrix metalloproteinases. Stem Cells 2006, 24:1254-1264.
94. Hattori K., Heissig B., Tashiro K., Honjo T., Tateno M., Shieh J.H., et al. Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells. Blood 2001, 97:3354-3360.
95. Wang X., Willenbring H., Akkari Y., Torimaru Y., Foster M., Al-Dhalimy M., et al. Cell fusion is the principal source of bone-marrow-derived hepatocytes. Nature 2003, 422(6934):897-901.
96. Zhao Y., Glesne D., Huberman E. A human peripheral blood monocyte derived subset acts as pluripotent stem cells. Proc Natl Acad Sci U S A 2003, 100:2426-2431.
97. Ruhnke M., Ungefroren H., Nussler A., Martin F., Brulport M., Schormann W., et al. Differentiation of in vitro-modified human peripheral blood monocytes into hepatocyte-like and pancreatic islet-like cells. Gastroenterology 2005, 128:1774-1786.
98. Liechty K.W., MacKenzie T.C., Shaaban A.F., Radu A., Moseley A.M., Deans R., et al. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med 2006, 6:1282-1286.
99. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
100. Lee O.K., Kuo T.K., Chen W.M., Lee K.D., Hsieh S.L., Chen T.H. Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 2004, 103(5):1669-1675.
101. Wang H.S., Hung S.C., Peng S.T., Huang C.C., Wei H.M., Guo Y.J., et al. Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells 2004, 22(7):1330-1337.
102. Banas A., Teratani T., Yamamoto Y., Tokuhara M., Takeshita F., Quinn G., et al. Adipose tissue-derived mesenchymal stem cells as a source of human hepatocytes. Hepatology 2007, 46(1):219-228.
103. Lee K.D., Kuo T.K., Whang-Peng J., Chung Y.F., Lin C.T., Chou S.H., et al. In vitro hepatic differentiation of human mesenchymal stem cells. Hepatology 2004, 40:1275-1284.
104. Kazemnejad S., Allameh A., Soleimani M., Gharehbaghian A., Mohammadi Y., Amirizadeh N., et al. Functional hepatocyte-like cells derived from human bone marrow mesenchymal stem cells on a novel 3-dimensional biocompatible nanofibrous scaffold. Int J Artif Organs 2008, 31(6):500-507.
105. Allameh A., Esmaeli S., Kazemnejad S., Soleimani M. Differential expression of glutathione S-transferases P1-1 and A1-1 at protein and mRNA levels in hepatocytes derived from human bone marrow mesenchymal stem cells. Toxicol In Vitro 2009, 23:674-679.
106. Aurich I., Mueller L.P., Aurich H., Luetzkendorf J., Tisljar K., Dollinger M.M., et al. Functional integration of hepatocytes derived from human mesenchymal stem cells into mouse livers. Gut 2007, 56:405-415.
107. Pan Q., Fouraschen S.M., Kaya F.S., Verstegen M.M., Pescatori M., Stubbs A.P. Mobilization of hepatic mesenchymal stem cells from human liver grafts. Liver Transpl 2011, 17(5):596-609.
108. Chen L., Tredget E.E., Liu C., Wu Y. Analysis of allogenicity of mesenchymal stem cells in engraftment and wound healing in mice. PLoS One 2009, 4:e7119.
109. Taniguchi H., Toyoshima T., Fukao K., Nakauchi H. Presence of hematopoietic stem cells in the adult liver. Nat Med 1996, 2:198-203.
110. Van Poll D., Parekkadan B., Cho C.H., Berthiaume F., Nahmias Y., Tilles A.W., et al. Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo. Hepatology 2008, 47:1634-1643.
111. Herrera M.B., Fonsato V., Gatti S., Deregibus M.C., Sordi A., Cantarella D., et al. Human liver stem cell-derived microvesicles accelerate hepatic regeneration in hepatectomized rats. J Cell Mol Med 2010, 14:1605-1618.
112. Yu Y., Yao A.H., Chen N., Pu L.Y., Fan Y., Lv L., et al. Mesenchymal stem cells over expressing hepatocyte growth factor improves small-for size liver grafts regeneration. Mol Ther 2007, 15:1382-1389.
113. Jiang Y., Jahagirdar B.N., Reinhardt R.L., Schwartz R.E., Keene C.D., Ortiz-Gonzalez X.R., et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002, 418:41-49.
114. Schwartz R.E., Reyes M., Koodie L., Jiang Y., Blackstad M., Lund T., et al. Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells. J Clin Invest 2002, 10:1291-1302.
115. Nagy P., Bisgaard H.C., Thorgeirsson S.S. Expression of hepatic transcription factors during liver development and oval cell differentiation. J Cell Biol 1994, 126(1):223-233.
116. Alison M., Golding M., Lalani E.N., Nagy P., Thorgeirsson S., Sarraf C. Wholesale hepatocytic differentiation in the rat from ductular oval cells, the progeny of biliary stem cells. J Hepatol 1997, 26(2):343-352.
117. Fougere-Deschatrette C., Imaizumi-Scherrer T., Strick-Marchand H., Morosan S., Charneau P., Kremsdorf D., et al. Plasticity of hepatic cell differentiation: bipotential adult mouse liver clonal cell lines competent to differentiate in vitro and in vivo. Stem Cells 2006, 24(9):2098-2109.
118. Theise N.D. Gastrointestinal stem cells. III. Emergent themes of liver stem cell biology: niche, quiescence, self-renewal, and plasticity. Am J Physiol Gastrointest Liver Physiol 2006, 290:189-193.
119. Zhao R., Duncan S.A. Embryonic development of the liver. Hepatology 2005, 41:956-967.
120. Kinoshita T., Miyajima A. Cytokine regulation of liver development. Biochim Biophys Acta 2002, 1592:303-312.
121. Runge D., Runge D.M., Bowen W.C., Locker J., Michalopoulos G.K. Matrix induced re-differentiation of cultured rat hepatocytes and changes of CCAAT/enhancer binding proteins. Biol Chem 1997, 378(8):873-881.
122. Kocarek T.A., Schuetz E.G., Guzelian P.S. Expression of multiple forms of cytochrome P450 mRNAs in primary cultures of rat hepatocytes maintained on matrigel. Mol Pharmacol 1993, 43(3):328-334.
123. Kamiya A., Kojima N., Kinoshita T., Sakai Y., Miyaijma A. Maturation of fetal hepatocytes in vitro by extracellular matrices and oncostatin M: induction of tryptophan oxygenase. Hepatology 2002, 35(6):1351-1359.
124. Ouchi H., Otsu K., Kuzumaki T., Iuchi Y., Ishikawa K. Synergistic induction by collagen and fibronectin of liver-specific genes in rat primary cultured hepatocytes. Arch Biochem Biophys 1998, 358(1):58-62.
125. Zavana B., Bruna P., Vindignib V., Amadoric A., Habelerc W., Pontissod P., et al. Extracellular matrix-enriched polymeric scaffolds as a substrate for hepatocyte cultures: in vitro and in vivo studies. Biomaterials 2005, 26:7038-7045.
126. Jiang J., Kojima N., Kinoshita T., Miyajima A., Yan W., Sakai Y., et al. Cultivation of fetal liver cells in a three-dimensional poly-l-lactic acid scaffold in the presence of oncostatin M. Cell Transplant 2002, 11:403-406.
127. Semino C.E., Merok J.R., Crano G.G., Panagiotakeos G., Zhang S. Functional differentiation of hepatocyte-like spheroid structures from putative liver progenitor cells in three-dimensional peptide scaffolds. Differentiation 2003, 71:262-270.
128. Kazemnejad S., Allameh A., Soleimani M., Gharehbaghian A., Mohammadi Y., Amirizadeh N., et al. Biochemical and molecular characterization of hepatocyte-like cells derived from human bone marrow mesenchymal stem cells on a novel three-dimensional biocompatible nanofibrous scaffold. J Gastroenterol Hepatol 2009, 24:278-287.
129. Wang J., Zong C., Shi D., Wang W., Shen D., Liu L., et al. Hepatogenic engineering from human bone marrow mesenchymal stem cells in porous polylactic glycolic acid scaffolds under perfusion culture. J Tissue Eng Regen Med 2012, 6(1):29-39.
130. Mooney D., Johnson L., Cima L. Principles of tissue engineering and reconstruction using polymer-cell constructs. Tissue inducing biomaterials, Materials Research Society symposium proceedings 1992, Vol. 252. Materials Research Society, Pittsburgh, PA.
131. Kneser U., Kaufmann P.M., Fiegel H.C., Pollok J.M., Kluth D., Herbst H., et al. Long-term differentiated function of heterotopically transplanted hepatocytes on three-dimensional polymer matrices. J Biomed Mater Res 1999, 47(4):494-503.
132. Higashiyama S., Noda M., Muraoka S., Hirose M., Ohgushi H., Kawase M., et al. Transplantation of hepatocytes cultured on hydorxyapatite into Nagase analbuminemia rats. J Biosci Bioeng 2003, 96:83-85.
133. Takeda M., Yamamoto M., Katsuhiro I., Higashiyama S., Hirose M., Ohgushi H., et al. Availability of bone marrow stromal cells in three-dimensional co-culture with hepatocytes and transplantation into liver-damaged mice. J Biosci Bioeng 2005, 1:77-81.
134. Takeda T., Kim T., Lee S., Davis J., Vacanti J. Hepatocyte transplantation in biodegradable polymer scaffolds using the Dalmatian dog model of hyperuricosuria. Transplant Proc 1995, 27(1):635-636.
135. Takeda T., Murphy S., Uyama S., Organ G., Schloo B., Vacanti J. Hepatocyte transplantation in swine using prevascularized polyvinyl alcohol sponges. Tissue Eng 1995, 1:253-259.
136. Meyburg J., Schmidt J., Hoffmann G.F. Liver cell transplantation in children. Clin Transplant 2009, 23(Suppl. 21):75-82. Review.
137. Mallet V.O., Gilgenkrantz H. Mobilizing stem cells to repair liver after surgery: dream or reality?. J Hepatol 2005, 43(5):754-756.
138. + bone marrow cells to the liver: a novel concept to support hepatic regeneration. Stem Cells 2005, 23:463-470.
139. + bone marrow stem cells for liver regeneration: initial experience. Radiology 2007, 243:171-179.
140. Terai S., Ishikawa T., Omori K., Aoyama K., Marumoto Y., Urata Y., et al. Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy. Stem Cells 2006, 24:2292-2298.
141. Kharaziha P., Hellström P.M., Noorinayer B., Farzaneh F., Aghajani K., Jafari F., et al. Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I-II clinical trial. Eur J Gastroenterol Hepatol 2009, 21(10):1199-1205.
142. Kim J.K., Park Y.N., Kim J.S., Park M., Paik Y.H., Seok J.Y., et al. Autologous bone marrow infusion activates the progenitor cell compartment in patients with advanced liver cirrhosis. Cell Transplant 2010, 19(10):1237-1246.
143. Ismail A., Fouad O., Abdelnasser A., Chowdhury A., Selim A. Stem cell therapy improves the outcome of liver resection in cirrhotics. J Gastro Cancer 2010, 41(1):17-23.
144. Amer M.E., El-Sayed S.Z., El-Kheir W.A., Gabr H., Gomaa A.A., El-Noomani N., et al. Clinical and laboratory evaluation of patients with end-stage liver cell failure injected with bone marrow-derived hepatocyte-like cells. Eur J Gastroenterol Hepatol 2011, 23(10):936-941.
145. Lyra A.C., Soares M.B., da Silva L.F., Braga E.L., Oliveira S.A., Fortes M.F., et al. Infusion of autologous bone marrow mononuclear cells through hepatic artery results in a short-term improvement of liver function in patients with chronic liver disease: a pilot randomized controlled study. Eur J Gastroenterol Hepatol 2010, 22(1):33-42.
146. Gaia A., Smedile P., Omede A., Olivero F., Sanavio F., Balzola F., et al. Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver disease. J Hepatol 2006, 45:13-19.
147. Yannaki E., Anagnostopoulos A., Kapetanos D., et al. Lasting amelioration in the clinical course of decompensated alcoholic cirrhosis with boost infusions of mobilized peripheral blood stem cells. Exp Hematol 2006, 34(11):1583-1587.
148. Gasbarrini A., Rapaccini G.L., Rutella S., et al. Rescue therapy by portal infusion of autologous stem cells in a case of drug-induced hepatitis. Dig Liver Dis 2007, 39(9):878-882.
149. + stem/progenitor cell populations mobilized into the blood by granulocyte colony-stimulating factor. Stem Cells 2006, 24:1822-1830.
150. + cells in patients with chronic liver disease. Cell Prolif 2008, 41(1):115-125.
151. Pai M., Zacharoulis D., Milicevic M.N., Helmy S., Jiao L.R., Levicar N., et al. Autologous infusion of expanded mobilized adult bone marrow-derived CD341 cells into patients with alcoholic liver cirrhosis. Am J Gastroenterol 2008, 103:1952-1958.
152. Han Y., Yan L., Han G., Zhou X., Hong L., Yin Z., et al. Controlled trials in hepatitis B virus-related decompensate liver cirrhosis: peripheral blood monocyte transplant versus granulocyte-colony-stimulating factor mobilization therapy. Cytotherapy 2008, 10(4):390-396.
153. Salama H., Zekri A., Zern M., Bahnassy A., Loutfy S., Shalaby S., et al. Autologous hematopoietic stem cell transplantation in 48 patients with end-stage chronic liver diseases. Cell Transplant 2010, 19(11):1475-1486.
154. Di Campli C., Zocco M.A., Saulnier N., et al. Safety and efficacy profile of G-CSF therapy in patients with acute on chronic liver failure. Dig Liver Dis 2007, 39(12):1071-1076.
155. Lorenzini S., Isidori A., Catani L., et al. Stem cell mobilization and collection in patients with liver cirrhosis. Aliment Pharmacol Ther 2008, 27(10):932-939.
156. Spahr L., Lambert J.-F., Rubbia-Brandt L., Chalandon Y., Frossard J.L., Giostra E., et al. Granulocyte-colony stimulating factor induces proliferation of hepatic progenitors in alcoholic steatohepatitis: a randomized trial. Hepatology 2008, 48(1):221-229.
157. Kallis Y.N., Alison M.R., Forbes S.J. Bone marrow stem cells and liver disease. Gut 2007, 56(5):716-724.
158. Muraca M. Evolving concepts in cell therapy of liver disease and current clinical perspectives. Dig Liver Dis 2011, 43(3):180-187.
159. Nussbaum J., Minami E., Laflamme M.A., Virag J.A., Ware C.B., Masino A., et al. Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response. FASEB J 2007, 21:1345-1357.
160. Chevallier N., Anagnostou F., Zilber S., Bodivit G., Maurin S., Barrault A., et al. Osteoblastic differentiation of human mesenchymal stem cells with platelet lysate. Biomaterials 2010, 31:270-278.
161. Kazemnejad S., Allameh A., Gharehbaghian A., Soleimani M., Amirizadeh N., Jazayeri M., et al. Efficient replacing of fetal bovine serum with human platelet releasate during propagation and differentiation of human bone marrow-derived mesenchymal stem cells to functional hepatocytes-like cells. Vox Sang 2008, 95:149-158.